Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 394,864,704
  • Shares Outstanding, K 2,686,520
  • Annual Sales, $ 71,890 M
  • Annual Income, $ 16,540 M
  • 36-Month Beta 0.80
  • Price/Sales 5.44
  • Price/Cash Flow 17.74
  • Price/Book 5.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
138.72 +5.91%
on 01/02/18
148.32 -0.94%
on 01/17/18
+5.12 (+3.61%)
since 12/18/17
3-Month
136.60 +7.55%
on 11/22/17
148.32 -0.94%
on 01/17/18
+6.24 (+4.44%)
since 10/18/17
52-Week
110.76 +32.65%
on 01/25/17
148.32 -0.94%
on 01/17/18
+32.22 (+28.09%)
since 01/18/17

Most Recent Stories

More News
Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?

We present four large cap drug companies, which are expected to repeat their last year's industry beating performance in 2018.

NVO : 56.51 (+0.18%)
JNJ : 146.92 (-0.04%)
ZTS : 76.33 (-0.57%)
ABBV : 103.81 (-0.53%)
AMGN : 187.59 (-0.22%)
Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label

Amgen (AMGN) gets an earlier-than-expected approval to include ENDEAVOR study OS data on Kyprolis label.

CELG : 101.72 (-0.29%)
JNJ : 146.92 (-0.04%)
VRTX : 157.19 (+0.13%)
AMGN : 187.59 (-0.22%)
Market at New Highs: Mega Cap ETFs & Stocks On A Roll

Inside mega cap ETFs & stocks hitting all-time highs with the skyrocketing market.

XLG : 199.57 (+0.05%)
JNJ : 146.92 (-0.04%)
BRK.B : 213.19 (-0.45%)
MGC : 96.25 (-0.11%)
DIA : 260.16 (-0.35%)
BA : 340.16 (-3.09%)
WMT : 104.30 (+1.56%)
J&J (JNJ) Hits New 52-Week High: What's Driving the Stock?

Promising data from several pivotal studies and a rapid pipeline progress contribute to a rally in Johnson & Johnson's (JNJ) shares.

CELG : 101.72 (-0.29%)
JNJ : 146.92 (-0.04%)
ABBV : 103.81 (-0.53%)
GSK : 38.17 (+0.05%)
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?

The positive trend seen in J&J's (JNJ) pharma segment sales in Q3 is likely to continue in Q4. Strong pharma performance and contribution from acquisitions should support the top line.

JNJ : 146.92 (-0.04%)
MRK : 61.13 (-1.45%)
PFE : 36.99 (-0.51%)
GSK : 38.17 (+0.05%)
Market at New Highs: Mega Cap ETFs & Stocks On A Roll

Inside mega cap ETFs & stocks hitting all-time highs with the skyrocketing market.

XLG : 199.57 (+0.05%)
JNJ : 146.92 (-0.04%)
BRK.B : 213.19 (-0.45%)
MGC : 96.25 (-0.11%)
DIA : 260.16 (-0.35%)
BA : 340.16 (-3.09%)
WMT : 104.30 (+1.56%)
New Real World Evidence Shows that Long-acting Antipsychotics Reduce Risk of Mortality for Patients Living with Schizophrenia Compared to Oral Antipsychotics

The Janssen Pharmaceutical Companies of Johnson & Johnson announce results of new real world evidence from a study of almost 30,000 people, which supports the benefits of long-acting antipsychotics (LATs)...

JNJ : 146.92 (-0.04%)
SmarTrend Watching for Potential Pullback in Shares of Johnson&Johnson After 1.00% Gain

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $146.03 to a high of $148.06. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of...

JNJ : 146.92 (-0.04%)
Johnson&Johnson Set to Possibly Pullback After Yesterday's Rally of 1.00%

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $146.03 to a high of $148.06. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of...

JNJ : 146.92 (-0.04%)
Global Medical Aesthetics Market 2018-2022 with Allergan, Dentsply Sirona, Galderma, Johnson & Johnson, Merz Pharma & Valeant Pharmaceuticals Dominating - Research and Markets

The "Global Medical Aesthetics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

JNJ : 146.92 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 148.25
1st Resistance Point 147.58
Last Price 146.92
1st Support Level 146.11
2nd Support Level 145.31

See More

52-Week High 148.32
Last Price 146.92
Fibonacci 61.8% 133.97
Fibonacci 50% 129.54
Fibonacci 38.2% 125.11
52-Week Low 110.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.